We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$21.7B
1-Year Est. Return
79.24%
This Fund
S&P 500
This Quarter
Est. Return
+33.18%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.7B
AUM Growth
+$2.61B
(+14%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-15.95%
Top 10 Holdings %
Top 10 Hldgs %
62.14%
Holding
194
New
19
Increased
30
Reduced
23
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$166M |
| 2 |
Roivant Sciences
ROIV
|
+$137M |
| 3 |
Immunovant
IMVT
|
+$130M |
| 4 |
BridgeBio Pharma
BBIO
|
+$96.5M |
| 5 |
Baidu
BIDU
|
+$94.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$498M |
| 2 |
Amazon
AMZN
|
+$398M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$372M |
| 4 |
Aon
AON
|
+$365M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.84% |
| 2 | Miscellaneous | 21.83% |
| 3 | Communication Services | 8.41% |
| 4 | Technology | 5.7% |
| 5 | Financials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRFS
126
Grifois
GRFS
$5.36B
| – | – |
-28,000
| Closed | -$225K |
|
127
Garrett Motion
GTX
$5.1B
| – | – |
-275,000
| Closed | -$5M |
|
128
Hyatt Hotels
H
$15.6B
| – | – |
-36,000
| Closed | -$5.18M |
|
129
Hims & Hers Health
HIMS
$6.49B
| – | – |
-10,000
| Closed | -$208K |
|
130
HealthEquity
HQY
$8.17B
| – | – |
-2,800
| Closed | -$234K |
|
131
Healthcare Realty
HR
$6.6B
| – | – |
-12,000
| Closed | -$204K |
|
132
Inter&Co
INTR
$2.56B
| – | – |
-614,500
| Closed | -$4.89M |
|
133
Ionis Pharmaceuticals
IONS
$9.66B
| – | – |
-4,800
| Closed | -$360K |
|
134
Iovance Biotherapeutics
IOVA
$3.94B
| – | – |
-26,000
| Closed | -$91.3K |
|
135
Ironwood Pharmaceuticals
IRWD
$709M
| – | – |
-13,000
| Closed | -$45.6K |
|
136
Krystal Biotech
KRYS
$11B
| – | – |
-1,000
| Closed | -$258K |
|
137
Littelfuse
LFUS
$10.5B
| – | – |
-15,000
| Closed | -$5.09M |
|
138
LivaNova
LIVN
$4.47B
| – | – |
-6,000
| Closed | -$381K |
|
139
Mastercard
MA
$513B
| – | – |
-435,071
| Closed | -$217M |
|
140
McKesson
MCK
$107B
| – | – |
-234,300
| Closed | -$203M |
|
141
Madrigal Pharmaceuticals
MDGL
$12.5B
| – | – |
-3,319
| Closed | -$1.74M |
|
142
Mirum Pharmaceuticals
MIRM
$6.14B
| – | – |
-3,000
| Closed | -$277K |
|
143
Merit Medical Systems
MMSI
$5.29B
| – | – |
-3,000
| Closed | -$207K |
|
144
Molina Healthcare
MOH
$10.6B
| – | – |
-35,000
| Closed | -$4.67M |
|
145
MasTec
MTZ
$18.7B
| – | – |
-17,000
| Closed | -$5.47M |
|
146
NeoGenomics
NEO
$2.24B
| – | – |
-19,000
| Closed | -$141K |
|
147
Nektar Therapeutics
NKTR
$2.61B
| – | – |
-4,000
| Closed | -$288K |
|
148
ServiceNow
NOW
$151B
| – | – |
-41,000
| Closed | -$4.29M |
|
149
Nuvation Bio
NUVB
$2.38B
| – | – |
-29,000
| Closed | -$124K |
|
|
NUVL
150
DELISTED
Nuvalent
NUVL
| – | – |
-3,000
| Closed | -$307K |
|
Similar funds
BG
IC
OSAM
SA
BPA
CHP
PAG
ETC
Farallon Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Farallon Capital Management held 194 positions worth $21.7B, up 14% from $19.1B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Farallon Capital Management withdrew a net $3.46B in Q2 2026, closing 105 positions and reducing 23 holdings. Its most notable exit was Charles Schwab, an estimated $372M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 47% a quarter earlier, followed by Miscellaneous and Communication Services.
Against the trend, Farallon Capital Management opened a new position in Parabilis Medicines Inc worth $64.8M.
- Farallon Capital Management's largest Q2 2026 buy was Parabilis Medicines Inc: 2,368,200 shares worth $64.8M.
- Farallon Capital Management added most to Boston Scientific in Q2 2026, an estimated $166M increase.
- Farallon Capital Management's biggest Q2 2026 reduction was Microsoft, cutting an estimated $498M.
- Farallon Capital Management fully exited Charles Schwab in Q2 2026, selling an estimated $372M.
- Farallon Capital Management's ten largest holdings make up 62% of its $21.7B portfolio in Q2 2026.
- Farallon Capital Management opened 19 new positions and closed 105 in Q2 2026.
- Farallon Capital Management's portfolio value rose 14% quarter-over-quarter to $21.7B.
Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.